Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids - Journal of Molecular and Cellular Cardiology

September 21,2024

Journal of Molecular and Cellular Cardiology期刊最新论文, 化学

Zuowen He's research works Tongji Hospital, Wuhan and other places

TGF-β1 induces cardiac hypertrophic responses via PKC-dependent

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent

Epoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic

Optimization of Amide-Based Inhibitors of Soluble Epoxide

Journal of Molecular and Cellular Cardiology

BRG1 and BRM function antagonistically with c-MYC in adult

Optimization of Amide-Based Inhibitors of Soluble Epoxide

Discovery and In Vivo Proof of Concept of a Highly Potent Dual

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent

Research & Publications - EicOsis